NOSHIR A DACOSTA MD NPI 1154300622

NPI Details

Noshir A Dacosta, MD is a hematology and oncology internal medicine in Smithtown, NY with 40 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Noshir A Dacosta, MD NPI is 1154300622. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

48 ROUTE 25A STE 209
SMITHTOWN, NY
ZIP 11787-449
Phone: (631) 751-3000
Fax: (631) 509-6559

The NPI 1154300622 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Phosphate level (HCPCS:84100)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Iron binding capacity (HCPCS:83550)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Vitamin d-3 level (HCPCS:82306)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Protein measurement, serum (HCPCS:84165)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Red blood count, manual test (HCPCS:85044)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Blood test, clotting time (HCPCS:85610)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Folic acid level, serum (HCPCS:82746)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Urinalysis, manual test (HCPCS:81002)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Hemoglobin a1c level (HCPCS:83036)
• Testosterone (hormone) level, total (HCPCS:84403)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Drawing of blood for a medical problem (HCPCS:99195)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Acute hepatitis panel (HCPCS:80074)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Injection, hydrocortisone sodium succinate, up to 100 mg (HCPCS:J1720)
• Albumin (protein) level (HCPCS:82040)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Bilirubin level, total (HCPCS:82247)
• Rheumatoid factor level (HCPCS:86431)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Ige (immune system protein) level (HCPCS:82785)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Transitional care management services for problem of moderate complexity (HCPCS:99495)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Measurement of total estradiol (hormone) (HCPCS:82670)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Blood smear for iron (HCPCS:85536)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Stool analysis for blood to screen for colon tumors (HCPCS:82270)
• Thyroid hormone evaluation (HCPCS:84479)
• Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies (HCPCS:87389)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 1/12/2006 and was last updated on 1/17/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.